United States · FDA National Drug Code directory
Amitiza
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64764-080_c2ca8178-4da1-42d1-a8b9-ff66dca82649
- Product NDC
- 64764-080
- Form
- CAPSULE, GELATIN COATED
- Composition / generic term
- lubiprostone
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20060131 / 20270331
Source-listed ingredients
- LUBIPROSTONE — 8 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
Package details are not available in this snapshot.
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →